SCHEMBL13192098

SCHEMBL13192098

COc1cc2ncnc(NCc3ccc(F)cc3)c2cc1OC

nearest known ligand 0.97

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGFR P00533 10/20 0.97
ERBB2 P04626 3/20 0.80
HTT P42858 4/20 0.79
KMT2A Q03164 3/20 0.79
KDM4E B2RXH2 2/20 0.79
MEN1 O00255 2/20 0.79
ALDH1A1 P00352 1/20 0.79
MAPK1 P28482 3/20 0.77
LMNA P02545 1/20 0.77
HPGD P15428 1/20 0.77
LCK P06239 1/20 0.75
HDAC3 O15379 1/20 0.70
HDAC4 P56524 1/20 0.70
HDAC1 Q13547 1/20 0.70
HDAC7 Q8WUI4 1/20 0.70
HDAC2 Q92769 1/20 0.70
HDAC10 Q969S8 1/20 0.70
HDAC11 Q96DB2 1/20 0.70
HDAC8 Q9BY41 1/20 0.70
HDAC6 Q9UBN7 1/20 0.70

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL642772 0.90 EGFR (0.80) EGFRERBB2HTTKMT2AKDM4E
SCHEMBL6181626 0.88 MEN1 (1.00) EGFRHTTKMT2AKDM4EMEN1
SCHEMBL22164645 0.88 HTT (0.81) EGFRERBB2HTTKMT2AKDM4E
Hydrochloric Acid SCHEMBL22290778 0.87 EGFR (0.80) EGFRERBB2HTTKMT2AKDM4E
Hydrochloric Acid SCHEMBL31429504 0.87 EGFR (0.80) EGFRERBB2HTTKMT2AKDM4E
SCHEMBL6179448 0.87 EGFR (1.00) EGFRHTTKMT2AKDM4EMEN1
SCHEMBL22299723 0.84 HTT (0.74) EGFRERBB2HTTKMT2AKDM4E
SCHEMBL22299722 0.84 HTT (0.74) EGFRERBB2HTTKMT2AKDM4E
SCHEMBL22169931 0.84 HTT (0.74) EGFRERBB2HTTKMT2AKDM4E
SCHEMBL643975 0.83 HDAC3 (1.00) EGFRERBB2HDAC3HDAC4HDAC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120258975-A1 Potent Small Molecule Inhibitors of Autophagy, and Methods of Use Thereof SHANGHAI INSTITUTE OF ORGANIC CHEMISTRY (CN) 2012-10-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120258975-A1 Potent Small Molecule Inhibitors of Autophagy, and Methods of Use Thereof ATG7, BECN1, SQSTM1 EGFR 2099/4885ERBB2 1952/4885HTT 4078/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.